Alternatively, hold down the Ctrl strong> '/' CMD 'key and press + to enlarge or' - 'on the keyboard to reduce the text size.

100%

High contrast mode is an accessibility feature for people with visual impairment.

Protection against falsified medicine

The objective of EU Directive 2011/62 is to protect prescription-only medicinal products from being falsified. Packaging for such medicinal products will bear new safety features and a unique identifier. Throughout EU a common repositories system will verify prescriptive drugs before it is delivered to a patient.

Protection against falsified medicine

The objective of EU Directive 2011/62 is to protect prescription-only medicinal products from being falsified. Packaging for such medicinal products will bear new safety features and a unique identifier. Throughout EU a common repositories system will verify prescriptive drugs before it is delivered to a patient.

The new regulations is in effect

Since February 9th 2019, it’s no longer be possible for falsifiers to introduce falsified, and sometimes life-threatening products, into the legal supply chain. Read more about the medicines supply chain and general information about the new regulations here:

Useful resources

News and project updates

See more news and project updates
See more project updates